Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors
US12378200B2 · kind B2 · utility
0Cited by
0References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2023 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Aug 9, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is related to a compound represented by the following structural formula: The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of aminocarboxymuconate semialdehyde decarboxylase (ACMSD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.